Christine Wilson and Noah Phillips

Open sea­son on PBMs but FTC votes against dig­ging in­to their an­ti-com­pet­i­tive prac­tices fur­ther

The abus­es of phar­ma­cy ben­e­fit man­agers were on full dis­play Thurs­day but the Fed­er­al Trade Com­mis­sion failed in ad­vanc­ing a mo­tion (2-2) to study these phar­ma mid­dle­men in more depth, which could lead to wider in­ves­ti­ga­tions.

FTC com­mis­sion­ers Noah Phillips and Chris­tine Wil­son vot­ed against con­duct­ing an FTC study on PBMs, claim­ing that it was not de­signed to study the com­pet­i­tive ef­fects of the PBMs, and it’s not clear this study would re­veal any­thing about pa­tients’ out-of-pock­et costs, ac­cord­ing to Phillips.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.